TY  - JOUR
AU  - Del-Rio, Maria-Luisa
AU  - Perez-Simon, Jose-Antonio
AU  - Rodriguez-Barbosa, Jose-Ignacio
PY  - 2022
DO  - 10.3389/fimmu.2022.887348
UR  - http://hdl.handle.net/10668/20584
T2  - Frontiers in immunology
AB  - The contribution of natural killer (NK) cells to tumor rejection in the context of programmed death-ligand 1/programmed death 1 (PD-L1/PD-1) blockade is a matter of intense debate. To elucidate the role of PD-L1 expression on tumor cells and the...
LA  - en
PB  - Frontiers Research Foundation
KW  - A20 leukemia cells
KW  - CD80
KW  - NK cells
KW  - PD-1
KW  - PD-L1
KW  - PD-L2
KW  - hybrid resistance
KW  - B7-H1 Antigen
KW  - Humans
KW  - Immune System Diseases
KW  - Killer Cells, Natural
KW  - Leukemia
KW  - Neoplasms
KW  - Parents
KW  - Programmed Cell Death 1 Receptor
TI  - Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid Resistance.
TY  - research article
VL  - 13
ER  -